A record year for biopharma M&A in 2019
- Visicell Medical Team
- Jan 14, 2020
- 1 min read
Updated: Dec 20, 2021
We saw lots of action in the biopharma merger and acquisition (M&A) space in 2019, headlined by Bristol-Myers Squibb acquiring Celgene for about $75 billion and AbbVie acquiring Allergan for $63 billion. With no signs of slowing down, what will we see in 2020?
Source: Biospace